This finding aligns with previous studies, including ours, which demonstrated that a rapid CD4+ T cell response is associated with higher humoral immunity to COVID-19 mRNA vaccination and that weaker CD4+ T cell responses after the first dose are observed in older adults (28, 40, 41). This evidence concerns the gene CD4 and COVID-19.